Her primary scientific interests are in Prostate cancer, Prostate, Pathology, Internal medicine and Prostatectomy. Her Prostate cancer research incorporates elements of Carcinogenesis, Biopsy, Odds ratio and Gynecology. Her Prostate study incorporates themes from Cancer research, Standardized uptake value and Gene expression.
Isabell A. Sesterhenn interconnects Intraepithelial neoplasia, Radiology and Adenocarcinoma in the investigation of issues within Pathology. Her Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Oncology. The various areas that Isabell A. Sesterhenn examines in her Prostatectomy study include Nuclear medicine, Confidence interval, Prostate biopsy, Stage and Primary tumor.
Her scientific interests lie mostly in Prostate cancer, Pathology, Prostate, Internal medicine and Cancer research. In general Prostate cancer, her work in Prostatectomy and PCA3 is often linked to TMPRSS2 linking many areas of study. Her work investigates the relationship between Pathology and topics such as Embryonal carcinoma that intersect with problems in Testicular cancer.
Her research in Prostate intersects with topics in Gene expression, Urology, Radiology and Adenocarcinoma. Her research integrates issues of Endocrinology and Oncology in her study of Internal medicine. Her study in Cancer research is interdisciplinary in nature, drawing from both Carcinogenesis, Gene, Immunology, LNCaP and Androgen receptor.
Prostate cancer, Internal medicine, Oncology, Prostate and Cancer research are her primary areas of study. Her Prostate cancer research integrates issues from Biopsy and Pathology. Her work on Malignancy as part of general Pathology study is frequently connected to World health, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Internal medicine research includes elements of Endocrinology, Gynecology, Germline and Single-nucleotide polymorphism. Her Oncology research focuses on subjects like Metastasis, which are linked to Tumor Status. Her biological study spans a wide range of topics, including Immunohistochemistry, Radiology, Gene expression and Disease.
Isabell A. Sesterhenn mostly deals with Prostate cancer, Internal medicine, Oncology, Prostate and Pathology. When carried out as part of a general Prostate cancer research project, her work on Androgen receptor is frequently linked to work in TMPRSS2, therefore connecting diverse disciplines of study. Her Internal medicine study combines topics in areas such as Endocrinology, ATF6 and Programmed cell death.
Isabell A. Sesterhenn combines subjects such as Prostatectomy, Biochemical recurrence, Case-control study and Receiver operating characteristic with her study of Oncology. Isabell A. Sesterhenn studied Prostate and Biopsy that intersect with Urine, PCA3 and Rectal examination. Her Pathology study combines topics from a wide range of disciplines, such as Prostate-specific antigen and LNCaP.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
Jonathan I. Epstein;Mahul B. Amin;Victor R. Reuter;Fathollah K. Mostofi.
The American Journal of Surgical Pathology (1998)
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Ziya Kirkali;Theresa Chan;Murugesan Manoharan;Ferran Algaba.
Renal medullary carcinoma. The seventh sickle cell nephropathy.
Charles J. Davis;F. K. Mostofi;Isabell A. Sesterhenn.
The American Journal of Surgical Pathology (1995)
Frequent Detection of Codon 877 Mutation in the Androgen Receptor Gene in Advanced Prostate Cancers
Jaya P. Gaddipati;David G. McLeod;Howard B. Heidenberg;Isabell A. Sesterhenn.
Cancer Research (1994)
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Zachary D. Goodman;Kamal G. Ishak;John M. Langloss;Isabell A. Sesterhenn.
Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT–Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens
Jun Miki;Bungo Furusato;Hongzhen Li;Yongpeng Gu.
Cancer Research (2007)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
Gyorgy Petrovics;Aijun Liu;Syed Shaheduzzaman;Bungo Furasato.
From the archives of the AFIP: extratesticular scrotal masses: radiologic-pathologic correlation.
Paula J Woodward;Cornelia M Schwab;Isabell A Sesterhenn.
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer
Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Ann W. Hsing;Yu-Tang Gao;Guan Wu;Xin Wang.
Cancer Research (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: